Mission
GENCURE IS ORGANIZED TO FOCUS ON REGENERATIVE MEDICINE AND THE UTILIZATION OF THE POWER OF HUMAN CELLS AND TISSUE TO ENHANCE LIVES AND ENABLE CLINICAL ADVANCEMENTS.
Public Charity
Gencure
Gencure, of SAN ANTONIO, TX, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $5.4M in revenue, $16.0M in expenses, $23.7M in total assets. 7 publicly reported grants to this organization, totaling roughly $1.3M, appear in IRS filings.
EIN: 462216869
SAN ANTONIO, TX
Blood Banks
NTEE: E61
Latest filing: 2024
Total Revenue$5.4M
Total Expenses$16.0M
Total Assets$23.7M
Grant Records7
Funding Total$1.3M
Filing Years2019–2024
Where $100 goes at Gencure
How Gencure divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$73
Programs
the work itself
$27
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $73 for programs
$73
During the reporting year, the organization advanced its enterprise-wide quality and operational infrastructure through several key initiatives
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
PROGRAM SUPPORT
$245,834
PROGRAM SUPPORT
$365,648
PROGRAM SUPPORT
$288,065
TEXAS CORD BLOOD BANK
$5,000
Texas Cord Blood Bank
$250,000
Showing up to 5 of 7 total records — full history available with membership.
Officers & Directors
Principal Global Market Development (effective 11/03/2024)
Amanda Whitelonis
SOLE MEMBER
Biobridge Global
General Manager, Biomanufacturing (thru 11/02/2024)
Geoffrey Kindt
SR. DIRECTOR, PROCESS DEV & CELL THERAPIES
Mari Lane Salmi
Director, Operations Biomanufacturing
Miguel Garza
VP, GENCURE OPERATIONS (thru 07/09/2024)
Milton Masayuki Pollard
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $5.4M | $16.0M | $23.7M |
| 2023 | $5.0M | $15.0M | $18.8M |
| 2022 | $5.0M | $13.7M | $21.8M |
| 2020 | $11.7M | $21.9M | $25.5M |
| 2019 | $15.4M | $21.8M | $26.6M |
Between 2019 and 2024, reported annual revenue declined from $15.4M to $5.4M (-65%), with total assets most recently reported at $23.7M.
Interactive year-over-year charts and full filing details available with membership.